BridgeBio Pharma, Inc. (BBIO) Capital expenditures 2017–2025
BridgeBio Pharma, Inc. (BBIO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.1MFY2025 · since FY2017: $464,000 → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1M | +17.6% |
| FY2024 | $933,000 | -28.6% |
| FY2023 | $1.3M | -72.9% |
| FY2022 | $4.8M | -63.6% |
| FY2021 | $13.2M | +76.2% |
| FY2020 | $7.5M | +185.0% |
| FY2019 | $2.6M | +21.1% |
| FY2018 | $2.2M | +369.4% |
| FY2017 | $464,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice